Susman Sergiu, Berindan-Neagoe Ioana, Petrushev Bobe, Pirlog Radu, Florian Ioan-Stefan, Mihu Carmen-Mihaela, Berce Cristian, Craciun Lucian, Grewal Ravnit, Tomuleasa Ciprian
Department of Pathology, Imogen Research Center.
Department of Morphological Sciences.
Cancer Manag Res. 2018 Apr 12;10:745-753. doi: 10.2147/CMAR.S150851. eCollection 2018.
After introducing the new molecules for the treatment of patients with tumoral pathology, the therapeutical decision will be taken depending on the molecular profile performed upon the harvested tissues. This major modification makes the molecular and morphological analysis an essential part in the clinical management of patients and the pathologist plays an important role in this process. The quality and reproducibility of the results are imperative today and they depend on both the reliability of the molecular techniques and the quality of the tissue we use in the process. Also, the genomics and proteomics techniques, used increasingly often, require high-quality tissues, and pathology laboratories play a very significant role in the management of all phases of this process. In this paper the parameters which must be followed in order to obtain optimal results within the techniques which analyze nucleic acids and proteins were reviewed.
在引入用于治疗肿瘤疾病患者的新分子后,治疗决策将根据对采集组织进行的分子特征分析来做出。这一重大变革使得分子和形态学分析成为患者临床管理的重要组成部分,病理学家在这一过程中发挥着重要作用。如今,结果的质量和可重复性至关重要,它们取决于分子技术的可靠性以及我们在该过程中使用的组织质量。此外,越来越常用的基因组学和蛋白质组学技术需要高质量的组织,病理实验室在这一过程所有阶段的管理中发挥着非常重要的作用。本文回顾了在分析核酸和蛋白质的技术中为获得最佳结果必须遵循的参数。